Skip to main content
Premium Trial:

Request an Annual Quote

Canary Foundation Gives $860K to BC Cancer Foundation to Develop Ovarian Cancer Blood Test

NEW YORK, April 6 (GenomeWeb News) - The Canary Foundation has given CA$1 million ($860,000) to the British Columbia Cancer Foundation to develop a blood test for the early detection of ovarian cancer, the organization said yesterday.


The funding will be used by the BC Cancer Agency on Vancouver Island as part of a collaborative research project involving multiple institutions.


According to Don Listwin, founder of the Canary Foundation, Michael Ball, CEO of proteomics software company GenoLogics was "instrumental" in encouraging the donation. "Initially, a common vision for the future of early cancer detection using proteomics research connected us," Listwin said in a statement.


Besides the BC Cancer Agency, the project involves researchers from the Fred Hutchinson Cancer Research Center; Stanford University; the University of Southern California; the University of California, San Francisco; and Intel.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.